Mink Therapeutics Inc
Biotechnology
Healthcare
INKT
3.98 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
15.95
52 week high
64.17
high
16.30
52 week low
0.00
low
14.82
growth
97.88 %
previous Close
16.30
P/E ratio
-14
market cap
66.26 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-4.24 M
99.85 %
eps
-1.06 %
-51.43 %
eps surprise
-1530.77 %
net profit margin
-423775100.00 %
0.00 %
operating incoming
-3.69 M
-45.62 %
net change in cash
-1.55 M
99.88 %
cash on hand
1.68 M
-48.01 %
cost of revenue
48.76 K
0.00 %
top top